Outcomes of an insurance company-sponsored multichannel chemistry screening initiative

Journal of Family Practice

Volumn 47, Issue 2, 1998, Pages 110-117

  Mold, James W ^a,b,c   Aspy, Cheryl B ^a,b   Lawler, Frank H ^a,b  

^a Univ of Oklahoma Hlth Sci Center ^*

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Clinical chemistry; Data analysis; Laboratory; Outcome assessment

Indexed keywords

ARTICLE; BLOOD CHEMISTRY; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH STATUS; LIPID BLOOD LEVEL; QUESTIONNAIRE; SCREENING TEST;

ADOLESCENT; ADULT; AGED; BLOOD CHEMICAL ANALYSIS; FEMALE; HEALTH; HEALTH PROMOTION; HUMANS; INSURANCE, HEALTH; MALE; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 0031851234     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Carmalt MH, Freeman P, Stephens AJ, Whitehead TP. Value of routine multiple blood tests in patients attending the general practitioner. BMJ 1970: 7:620-3.
2. Friedman GD, Goldberg M, Ahuja JN, Siegelaub AB, Bassis ML, Collen MI. Biochemical screening tests: effect of panel size on medical care. Arch Intern Med 1972; 129:91-7.
3. Schneiderman LJ, DeSalvo L, Baylor S, Wolf PL. The "abnormal" screening laboratory results: its effect on physician and patient. Arch Intern Med 1972; 129:88-90.
4. Romm FJ. Routine chemistry testing. Fam Med 1986;18:230-2.
5. Ruttimann S, Dreifuss M, Clemencon D, DiGallo A, Dubach UC. Multiple biochemical blood testing as a case-finding tool in ambulatory medical patients. Am J Med 1993; 94:141-8.
6. Cebul RD, Beck JR. Biochemical profiles: applications in ambulatory screening and preadmission testing of adults. Ann Intern Med 1987; 106:403-13.
7. Cullen SA. Place of biochemical tests in aircrew medical examinations. Aviat Space Environ Med 1989; A48-9.
8. Durbridge TC, Edwards F, Edwards RG, Atkinson M. Evaluation of benefits of screening tests done immediately on admission to hospital. Clin Chem 1976; 22:968-71.
9. Fletcher SW, Sourkes M, Rabzel M, Fletcher RH. Multiphasic screening: case-finding tool in a teaching hospital medical clinic. JAMA 1977; 237:887-91.
10. Kaplan EB, Sheiner LB, Boeckmann AJ, Roizen MF, Beal SL. The usefulness of preoperative laboratory screening. JAMA 1985; 253:3576-81.
11. Rubenstein LV, Ward NC, Greenfield S. In pursuit of the abnormal serum alkaline phosphatase: a clinical dilemma. J Gen Intern Med 1986; 1:38-43.
12. Sheard SC. Haematological and biochemical screening of potential Royal Naval aircrew. J Roy Nav Med Serv 1991; 77:11-6.
13. Williamson E, VanPeenen HJ. Patient benefit in discovering occult hyperparathyroidism. Arch Intern Med 1974; 133: 430-1.
14. Bates B, Yellin JA. The yield of multiphasic screening. JAMA 1972; 222:74-8.
15. Olsen DM, Kane R.L, Proctor PH. A controlled trial of multiphasic screening. N Engl J Med 1976; 294:925-30.
16. Witte DL, Angstadt DS, Schweitzer JK. Chemistry profiles in "wellness programs": test selection and participant outcomes. Clin Chem 1988; 34:1447-50.
17. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978; 299:741-4.
18. Charlson ME, Alderman M, Melcher L. Absenteeism and labelling in hypertensive subjects. Am J Med 1982; 73:165-70.
19. Lerman C, Miller SM, Scarborough R, et al. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991; 165:658-62.
20. Cadman D, Chambers LlW, Walter SD, et al. Evaluation of public health preschool child development screening: the process and outcomes of a community program. Am J Public Health 1987; 77:45-51.
21. Hampton MI, Anderson J, Lavizzo BS, Bergman AB. Sickle cell nondisease. Am J Dis Child 1974; 128:58-61.
22. Berman AB, Stamm SJ. The morbidity of cardiac nondisease in schoolchildren. New Eng J Med 1967; 276:1008-13.
23. Sorenson JR, Levy HL, Mangione TW, Sepe SJ. Parental response to repeat testing of infants with "false positive" results in a newborn screening program. Pediatrics 1986; 73:183-7.
24. Fyro K, Bodegard G. Four year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr Scand 1987; 76:107-14.
25. Berwick DM. Screening in health fairs. JAMA 1985; 254:1492-8.
26. Donaldson RM. The trouble with screening. Cortlandt Forum 1988: 11.
27. Lentsch PM. Screening of older adults - an ethical issue [editorial]. J Gerontol Nurs 1981; 7:215-6.
28. Hyman DJ, Flora JA, Reynolds KD, et al. The impact of public cholesterol screening on diet, general well-being, and physician referral. Am J Prev Med 1991; 7:268-72.
29. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1975; 273:129-35.
30. Gliklich RE, Hilinski JM. Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res 1995; 4:27-32.
31. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997; 50:79-93.
32. Pouchot J, Buillemin F, Coste J, Bregeon C, Sany J. Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol 1996; 23:52-60.